日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

An increase in splenic volume after first-line immunotherapy is associated with worse PFS in patients with metastatic renal cell carcinoma

一线免疫治疗后脾脏体积增大与转移性肾细胞癌患者的无进展生存期（PFS）较差相关。

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf397
Palmateer, Gregory; Yildirim, Ahmet; Goodstein, Taylor; Patil, Dattatraya; Patel, Samay; Joshi, Shreyas; Narayan, Vikram; Brown, Jacqueline T; Nazha, Bassel; Ahmed, Shahid S; Ciuro, Jordan; Carthon, Bradley C; Kucuk, Omer; Kissick, Haydn; Ogan, Kenneth; Bilen, Mehmet A; Master, Viraj A
肿瘤
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Case Report: Looks can deceive: acute postoperative progressive renal dysfunction and hyperkalemia without significant hydronephrosis

病例报告：外表可能具有欺骗性：急性术后进行性肾功能障碍和高钾血症，但无明显肾积水

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1685283
Lahiji, Reza; Yildirim, Ahmet; Luke, William; Storino Ramacciotti, Lorenzo; Morton, Ernest A; Helman, Talia Avigail; Nguyen, Jocelyn; Grajales, Valentina; Joshi, Shreyas S; Narayan, Vikram M; Nabavizadeh, Behnam; Hajiha, Mohammad; Nabavizadeh, Reza; Park, Peter J; Ogan, Kenneth; Bilen, Mehmet A; Master, Viraj A
发表日期：2026
文献求助 收藏

[(18)F]-Fluciclovine or [(68)Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial

[(18)F]-氟西洛文或[(68)Ga]-PSMA-11分子影像指导前列腺癌根治性前列腺切除术后挽救性放疗剂量递增：EMPIRE-2试验

期刊:
影响因子:
doi:10.1016/j.eururo.2025.12.003
Jani, Ashesh B; Dhere, Vishal R; Goyal, Subir; Schreibmann, Eduard; Patel, Pretesh R; Hershatter, Bruce; Shelton, Joseph W; Hanasoge, Sheela; Sebastian, Nikhil T; Patel, Sagar A; Halkar, Raghuveer; Cooper, Sherrie; Fielder, Bridget; Abiodun-Ojo, Olayinka A; Lawal, Ismaheel; Mushtaq, Aliza; Master, Viraj A; Joshi, Shreyas S; Kucuk, Omer; Bilen, Mehmet A; Schuster, David M
MPI
肿瘤
前列腺癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United States

美国局限性前列腺癌基因组分类器检测的社会人口学特征、医疗保健成本和治疗意义

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO-25-00406
Janopaul-Naylor, James R; Patil, Dattatraya; Joshi, Shreyas; Sanda, Martin G; Sebastian, Nikhil; Salari, Kamran; Dodge, Jade; Dhere, Vishal R; Hershatter, Bruce W; Patel, Pretesh R; Jani, Ashesh B; Filson, Christopher; Patel, Sagar A
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy

分子分型预测临床局限于器官内的膀胱癌患者行根治性膀胱切除术后的病理分期升级和生存结局

期刊:European Urology Open Science
影响因子:4.5
doi:10.1016/j.euros.2024.12.009
de Jong, Joep J; Proudfoot, James A; Daneshmand, Siamak; Svatek, Robert S; Narayan, Vikram; Davicioni, Elai; Joshi, Shreyas; Dahmen, Aaron; Li, Roger; Inman, Brant A; Shah, Paras; Chaplin, Iftach; Wright, Jonathan; Gibb, Ewan A; Lotan, Yair
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy

基于管腔非编码RNA的基因组分类器证实，接受根治性膀胱切除术治疗的临床局限性膀胱癌患者预后良好。

期刊:Bju International
影响因子:4.4
doi:10.1111/bju.16572
de Jong, Joep J; Proudfoot, James A; Daneshmand, Siamak; Svatek, Robert S; Narayan, Vikram; Gibb, Ewan A; Davicioni, Elai; Joshi, Shreyas; Dahmen, Aaron; Li, Roger; Inman, Brant A; Shah, Paras; Chaplin, Iftach; Wright, Jonathan; Lotan, Yair
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Overcoming resistance in advanced urothelial carcinoma: mechanisms of escape from antibody-drug conjugates and FGFR3 inhibition

克服晚期尿路上皮癌的耐药性：抗体药物偶联物和FGFR3抑制剂的逃逸机制

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1654771
Wummer, Brandon; Schwartz, Michael; Ciuro, Jordan; Ahmed, Shahid; Joshi, Shreyas S; Narayan, Vikram M; Carthon, Bradley C; Bilen, Mehmet Asim; Brown, Jacqueline T
FGFR3
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Preoperative β2 Microglobulin Is a Prognostic Factor in Patients with Renal Cell Carcinoma and Normal Kidney Function

术前β2微球蛋白是肾细胞癌伴肾功能正常患者的预后因素

期刊:Research and Reports in Urology
影响因子:2.7
doi:10.2147/RRU.S528585
Palmateer, Gregory; Nicaise, Eduoard H; Goodstein, Taylor; Patil, Dattatraya H; Joshi, Shreyas S; Narayan, Vikram M; Ogan, Kenneth; Master, Viraj A
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.

Trop-2 和 Ephrin B2 在分化异常的尿路上皮癌和侵袭性尿路上皮癌亚型中的表达

期刊:American Journal of Clinical Pathology
影响因子:1.9
doi:10.1093/ajcp/aqae161
Case Katherine B, Martini Dylan J, Dababneh Melad N, Bidot Samuel, Nazha Bassel, Brown Jacqueline, Joshi Shreyas, Narayan Vikram, Parihar Vaunita, Saeed Faisal, Bilen Mehmet Asim, Harik Lara R
肿瘤
发表日期：2025
文献求助 收藏

PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation

PD-L1和nectin-4表达及分化程度不同的膀胱癌的基因组特征

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.35465
Martini, Dylan J; Case, Katherine B; Gratz, Derrik; Pellegrini, Kathryn; Beagle, Elizabeth; Schneider, Thomas; Dababneh, Melad; Nazha, Bassel; Brown, Jacqueline T; Joshi, Shreyas S; Narayan, Vikram M; Ogan, Kenneth; Master, Viraj A; Carthon, Bradley C; Kucuk, Omer; Harik, Lara R; Bilen, Mehmet Asim
PD-L1
肿瘤
肿瘤免疫
膀胱癌
发表日期：2024
文献求助 收藏